FFFMX | SVACX | FFFMX / SVACX | |
Total Expense Ratio | 0.32 | 1.87 | 17% |
Annual Report Gross Expense Ratio | 0.32 | 1.93 | 17% |
Fund Existence | 5 years | 21 years | - |
Gain YTD | 14.204 | 11.052 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1500 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111B | 8.67B | 1,280% |
Annual Yield % from dividends | 1.72 | 2.22 | 77% |
Returns for 1 year | 5.60 | 4.02 | 139% |
Returns for 3 years | 41.37 | 25.70 | 161% |
Returns for 5 years | N/A | 58.00 | - |
Returns for 10 years | N/A | 34.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 75.69 | 0.46 | +0.61% |
Janus Henderson Global Life Sciences D | |||
GMVAX | 16.47 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity A | |||
FBAFX | 39.01 | 0.04 | +0.10% |
American Funds American Balanced 529-F-2 | |||
SGQAX | 46.26 | -0.03 | -0.06% |
DWS International Growth A | |||
TPISX | 14.04 | -0.08 | -0.57% |
Nuveen Quant Intl Small Cap Eq Premier |